17
September 2024
Kooth Plc
("Kooth", the
"Company" or the
"Group")
Half Year
Results
Record revenue of £32.5m
driven by strong US growth
Adjusted EBITDA of
£7.8m
Kooth (AIM: KOO), a global leader in
youth digital mental well-being, announces unaudited results for
the six months ended 30 June 2024. All figures relate to this
period unless otherwise stated.
Strategic and post-period end highlights
●
Significant progress in key US market, which has
grown over two years to approximately 70% of total Annual Recurring
Revenues
○ Delivering
behavioural health care in California, accessible to the State's
population of 13-25 year-olds, with sign-ups in every one of
California's 58 counties following service launch in January
2024
○ First US
private sector partnership with Aetna Better Health® of Illinois to
support youth in low-income families
○ Continued
service delivery in Pennsylvania, with 88% of students reporting
they received the support they needed and an initial tranche of new
funding recently awarded
●
Ongoing investment in product development
highlighted by Soluna platform expansion with new video coaching
and care navigation capabilities
●
Maintained position as NHS England's largest
single access provider for mental health support for under 18s
despite ongoing macro-economic conditions and broader NHS
backdrop
Financial Highlights
●
Revenues up 179% to £32.5m (2023: £11.7m), driven
by US expansion
●
Annual Recurring Revenue (ARR) up 181% to £60.0m
(2023: £21.4m)
●
Gross margin up 15.6ppt to 82.4% (2023:
66.8%)
●
Adjusted EBITDA to £7.8m (2023: £0.0m)
●
Profit after tax of £3.9m (2023: £0.5m
loss)
●
Robust balance sheet; net cash of £14.9m (2023:
£5.9m) supports investment for long-term growth
Outlook
●
US market:
o Significant opportunity driven by the continued need from both
State Governments and private-sector healthcare service providers
to invest further in youth mental health services
o Further two pilot contracts expected to be signed in the
current financial year
●
UK market:
o The
new Government has highlighted its commitment to improving mental
health services and invest more in prevention and digital, however
headwinds remain with NHS financial pressures driving short-term
focus
o Kooth to continue demonstrating the long-term impact and
savings that it generates where it is commissioned and focus on
advocacy to help inform future policy
o Investing in bringing Soluna to the UK in Q2 2025 to grow
impact and expand uptake
●
The Group expects to deliver strong adjusted
EBITDA and margin for the full year
●
Robust balance sheet to enable long-term
investment to meet increasing demand for Kooth's
services
Tim
Barker, Chief Executive Officer of Kooth, said:
"We have delivered excellent financial results in the first
six months of 2024 but, more importantly, we have significantly
expanded our operations and are now delivering our services to more
children and young people than ever before. This growth has been
led primarily by the US market, which now accounts for
approximately 70% of our business.
In
the UK we continue to demonstrate the long-term impact and savings
that Kooth delivers where it is commissioned and are working to
bring our market-leading Soluna product to the UK in Q2 2025 to
ensure that we continue to differentiate Kooth and grow our reach
and impact. We believe that the new Government is committed to
improving mental health provision, and eagerly await the revised
10-year NHS strategy due in spring as a catalyst for change, but
expect financial pressures to remain in the
short-term.
As
a Company we are focused on delivering early-intervention mental
health support for children and young people which has proven to
offer significant financial benefit to global healthcare systems
and economies, both through our own studies and those carried out
by third parties. Mental health and health inequality are two of
the major crises facing people today, and we are proud that our
services are firmly targeted at meeting both of these
challenges."
Financial headlines
|
Six
months ended 30 June 2024
|
|
Six
months ended 30 June 2023
|
|
Change
|
|
£'000
|
|
£'000
|
|
|
Revenue
|
|
|
|
|
|
Total revenue
|
32,494
|
|
11,660
|
|
+178.7%
|
Annual Recurring Revenue
|
60,040
|
|
21,376
|
|
+180.9%
|
|
|
|
|
|
|
Gross profit
|
26,767
|
|
7,788
|
|
+243.7%
|
Gross margin
|
82.4%
|
|
66.8%
|
|
+15.6ppt
|
|
|
|
|
|
|
Adjusted EBITDA
|
7,841
|
|
9
|
|
n/m
|
|
|
|
|
|
|
Profit/(Loss) after tax for the
period
|
3,920
|
|
(525)
|
|
+846.6%
|
|
|
|
|
|
|
Cash generation
|
3,936
|
|
(2,642)
|
|
+249.0%
|
Cash position
|
14,940
|
|
5,850
|
|
+155.4%
|
|
|
|
|
|
|
Basic earnings per share
(£)
|
0.11
|
|
(0.02)
|
|
+775.5%
|
Diluted earnings per share
(£)
|
0.10
|
|
(0.02)
|
|
+740.9%
|
Enquiries
Kooth plc
|
investorrelations@kooth.com
|
Tim Barker, CEO
|
|
Sanjay Jawa, CFO
|
|
|
|
Stifel, Nominated Advisor & Sole Broker
|
+44 (0) 20 7710 7600
|
Ben Maddison, Nick Harland, Erik
Anderson, Ben Good
|
|
|
|
FTI
Consulting, Financial PR
|
kooth@fticonsulting.com
|
Ben Atwell, Alex Shaw
|
|
About Kooth
Kooth (AIM:KOO) is a global leader
in youth digital mental well-being. Our mission is to provide
accessible and safe spaces for everyone to achieve better mental
health. Our platform is clinically robust and accredited to provide
a range of therapeutic support and interventions. All our services
are predicated on easy access to make early intervention and
prevention a reality.
Kooth is a fully safeguarded and
pre-moderated community with a library of peer and professional
created content, alongside access to experienced online
counsellors. There are no thresholds for support and no waiting
lists.
Kooth is the longest standing
digital mental health provider to hold a UK-wide accreditation from
the British Association of Counselling and Psychotherapy (BACP) and
according to NHS England data for 2022/23 is now the largest single
access provider for mental health support for under 18s.
In 2021, Kooth began executing on
its international expansion strategy, with an initial focus on the
US market. This focus is due to the growing recognition of the
importance of improving youth mental health in this key global
healthcare market, with 1-in-6 people aged 6-17 experiencing a
mental health disorder each year.
For more information, please
visit www.koothplc.com.
Chief Executive's Review
Strong US momentum and
expansion
We have delivered record results
across our financial metrics during the first half of 2024, with
revenue increasing 179% and ARR by 181% when compared to 2023. We
have also seen significant momentum for Kooth in the US,
highlighted by the successful launch of Soluna on 1 January in
California, a key foundational pillar in the state's masterplan to
transform youth mental healthcare. When combined with our robust
balance sheet, we are well placed to continue investing in our
services to improve the mental health of the population and deliver
health economic outcomes to save healthcare systems
money.
The benefit of this investment can
be seen in Soluna, which is already making an impact with young
people from all 58 counties in California, with 53% of users coming
from communities disproportionately affected by health and economic
inequities. The significant uptake among young people impacted by
inequality underscores the importance of our role in addressing
health inequities in the US. We continue to see encouraging data
which demonstrate the benefits of the platform. For example, among
those engaging with mental health coaches, 70% report positive
outcomes from single-session therapy, and 95% would recommend
Soluna to a friend.
Since launching Soluna we have also
enhanced its capabilities. In the first half of the year, we
introduced video-based 1-2-1 coaching to complement existing chat
and phone options. We also launched care navigation support, making
Soluna a digital front door for mental healthcare and welfare
services across California. This allows us to quickly connect young
people needing more acute or specialised care with appropriate
local services. Looking ahead, we anticipate that these
advancements will not only help establish Soluna as a strategic
platform for transforming mental healthcare in California, but also
serve as a strong foundation for broader US and UK
expansion.
We continued to make progress in the
US with our first private sector engagement, an initial one-year
Medicaid partnership with Aetna Better Health® of Illinois.
Medicaid - the state- and federally-funded insurance programme for
low-income families - represents a $30.1 billion annual
cost[1] for youth behavioural health, with around
40 million children and young people across the US covered by
Medicaid. Partnering with Medicaid providers like Aetna offers a
differentiated route to market for Kooth and gives us the
opportunity to deliver our services directly to millions of
children and young people who may otherwise not be covered by
State-led programmes. Given the growing demand and cost of
behavioural healthcare, our partnership with Aetna aims to provide
early intervention support to young people, reducing the need for
more intensive and expensive downstream care. The service in
Illinois launched in August, with our ambition to demonstrate our
initial impact in Chicago before expanding across the state and
potentially into the 15 other states where Aetna Better Health®
operates.
Finally, in Pennsylvania, we
continue to provide support to the student population as we
finalise our commercial agreements with the state. While we saw a
successful pilot of the service with one-in-ten of the eligible
population using Kooth in its first year, the complexities of
negotiating bipartisan agreements in the state have been a key
learning for us as we look to future contracts elsewhere.
Post-period end, an extended contract covering a period till
mid-2025 has been agreed with the Department of Human Services,
supported by an initial tranche of funding. Kooth is continuing to
negotiate with relevant parties within Pennsylvania to finalise the
total contract award and will update the market in due
course.
Navigating the UK
market
We have been pleased to see the
positive indications from the new Government on the critical
importance of improving access and investing in preventative mental
health services, however the systemic challenges within the NHS,
and the number of competing priorities faced in the short-term,
suggest that substantial change will likely take some time. To
ensure that our voice continues to be heard, we have bolstered our
advocacy efforts as a champion and pioneer in digital mental
health. For example, in June we hosted our first UK-US knowledge
exchange event, bringing together stakeholders from California's
mental health ecosystem with UK policy influencers and third-sector
leaders. The events focused on the shared ambition and learnings in
building a healthcare ecosystem focused on prevention, designing
services 'with and for' young people, and improving access. We also
intend to demonstrate our commitment to innovation by launching
Soluna in the UK, expected in Q2 2025, which we believe will help
grow usage and impact of the service.
More broadly, our strategic focus
has been on delivering value and impact within our existing
contracts and demonstrating the clinical benefits and
cost-effectiveness of early digital intervention. We believe that
if Kooth can continue to demonstrate its potential to have a
positive impact on both youth mental health and healthcare system
savings, we will play a crucial role in the future of the
NHS.
Current trading and outlook
Looking ahead, our focus remains on
driving innovation and scaling our technology platform and
organisation to meet the growing demand for our services. In the
US, we see significant opportunities as State Governments and
Medicaid payors continue to invest in improving youth mental health
provision. Given this investment, and recognition of the severe
unmet need, we are optimistic about expanding our presence and
demonstrating the value of Kooth's solutions in additional markets.
This is supported by a strong pipeline of new business in the US,
where we anticipate two new pilot contracts being signed later this
year.
In the UK, our commitment to
delivering impactful mental health support and advocating for
digital transformation remains our key priority. We will continue
to invest in our technology, systems and talent to support this
mission, leveraging our experience and success in the US to inform
and advocate for transformative change.
We remain confident in our ability
to deliver strong results for the full year. Kooth is
well-positioned to address the global challenge of youth mental
health, and we will continue to focus on scaling our impact,
enhancing our services and fulfilling our mission to provide
accessible mental health support to those who need it
most.
Tim
Barker
Chief Executive
Chief Financial Officer's review
Kooth delivered a strong performance
in the period, supported by record increases across revenue and
annual recurring revenue, a strong gross margin as well as
significant investment in our platform and the business for the
half year ended 30 June 2024 as compared to the six months ended 30
June 2023.
Key
Performance Indicators
Total Revenue
H1 2020
|
H1 2021
|
H1 2022
|
H1 2023
|
H1 2024
|
|
|
|
|
|
£5.9m
|
£8.0m
|
£9.0m
|
£11.7m
|
£32.5m
|
|
|
|
|
|
Revenue is a KPI which reflects the
work we are doing and the fees received over a period of time for
that work. It has been driven by US growth, fee uplifts within
'Children and Young People' offset by churn in our UK revenue
lines.
Annual Recurring Revenue
H1 2020
|
H1 2021
|
H1 2022
|
H1 2023
|
H1 2024
|
|
|
|
|
|
£13.1m
|
£16.6m
|
£18.5m
|
£21.4m
|
£60.0m
|
Annual Recurring Revenue (ARR) is
the annualised revenue of customers engaged or closed as at the
period end and is an indication of the upcoming annual value of the
recurring revenue. This is used by management to monitor the
long-term revenue growth of the business. Our growth in the period
is predominantly driven by US expansion in California.
Gross Margin
H1 2020
|
H1 2021
|
H1 2022
|
H1 2023
|
H1 2024
|
|
|
|
|
|
69.6%
|
69.4%
|
68.4%
|
66.8%
|
82.4%
|
Gross margin is gross profit
expressed as a percentage of revenue. Direct costs are the costs of
our practitioners directly involved in the delivery of our
services. We have seen an increase in gross margin driven by the US
with the roll out of the Soluna app where we are initially seeing
lower practitioner costs as contract usage ramps up and a greater
use of the community and self guided tools. Gross margin has
further benefitted from California revenues including a
contribution to platform development, the cost of which is either
included in overheads or capitalised and amortised.
Adjusted EBITDA
H1 2020
|
H1 2021
|
H1 2022
|
H1 2023
|
H1 2024
|
|
|
|
|
|
£0.5m
|
£1.1m
|
£0.5m
|
£0.0m
|
£7.8m
|
Earnings before interest, tax,
depreciation and amortisation in the period, adjusted for share
based payments and exceptional costs. This metric provides a more
comparable indication of the Group's core business performance by
removing the impact of non-trading items that are reported
separately. Growth has been driven by revenue from our California
contract and a strong gross margin.
Net
Cash
H1 2020
|
H1 2021
|
H1 2022
|
H1 2023
|
H1 2024
|
|
|
|
|
|
£0.6m
|
£8.8m
|
£8.3m
|
£5.9m
|
£14.9m
|
Net Cash is a key metric as it
provides assurance on our ability to invest to grow the business,
as well as provide comfort to customers from a vendor risk
perspective. The increase in the period derives from working
capital management as well as cash generated from operations offset
by investment in our platforms.
Population coverage
H1 2020
|
H1 2021
|
H1 2022
|
H1 2023
|
H1 2024
|
|
|
|
|
|
5.9m
|
9.5m
|
15.1m
|
16.7m
|
19.9m
|
The total number of people who have
access to the Kooth service is a good indicator of our
accessibility. The H1 2024 figure represents the additional
population added in California less churn within our UK adult
contracts.
Service user logins
H1 2020
|
H1 2021
|
H1 2022
|
H1 2023
|
H1 2024
|
|
|
|
|
|
1.0m
|
1.2m
|
1.4m
|
1.4m
|
1.4m
|
The number of logins to Kooth from
users over the last twelve months (LTM), demonstrating usage of our
service.
Revenue
Revenue increased by 179% to £32.5m
(2023 H1: £11.7m), Annual Recurring Revenue (ARR) grew by 181% to
£60.0m (2023 H1: £21.4m), driven by the California contract win in
H2 2023.
US Revenue in H1 2024 was £23.3m
(2023 H1: £1.8m) all of which was recurring revenue (comprising
income invoiced for services that are repeatable, consumed and
delivered on a monthly basis over the term of a customer
contract).
UK revenue decreased by 6% to £9.2m
(2023 H1: £9.8m) reflecting an increase in churn in our English
contracts being a combination of funding unavailable to continue
pilot contracts, reductions as contracts consolidated and a single
competitive loss. Overall, UK churn for the previous 12 months was
13% (£2.4m) giving net revenue retention, measured by the total
value of on-going ARR at the period-end from clients in place 12
months earlier as a percentage of the opening ARR from those
clients, for the period to 30 June 2024 of 92%. This has decreased
from 100% recorded in H1 2023.
Gross Profit
Gross Profit increased 244% from
£7.8m to £26.8m, with gross margin increasing to 82.4% (2023 H1:
66.8%). Direct costs are the costs of the practitioners directly
involved in the delivery of our services, a total of 303 at the
period-end (2023 H1: 251 heads). Gross margin benefitted from the
contribution within US revenues to the development of the Soluna
platform where costs are either capitalised and amortised or
included in overheads as well as lower practitioner costs as
contract usage ramps up and a greater use of the community and self
guided tools in the platform. We also saw productivity improvements
and the churn of lower margin contracts in the UK leading to a
small increase in UK gross margins.
Foreign currency impact
The US Dollar/GBP exchange rate was
relatively stable during the period under review during which the
Group had approximately 72% of revenues and 47% of expenses
denominated in US Dollars. The Group's focus on management of
foreign currency risk resulted in a small foreign currency gain of
£0.1m (2023 H1: nil). Post period end we have seen sterling
strengthen against the US dollar which is expected to impact
revenue in the second half. This is not anticipated to have a
significant influence on margin or profitability.
Adjusted EBITDA
Adjusted EBITDA in the period
increased from £0.0m to £7.8m, with the £19.0m increase in gross
profit outweighing a £11.2m increase in administrative expenses
(excluding amortisation, depreciation and share based payments).
Whilst UK costs increased in line with salary inflation, the
majority of the increase related to the first full period of costs
following the build out of the US teams supporting our California
contract alongside significant promotion and marketing costs in
support of raising user awareness and engagement including hard to
reach communities. Finally, we saw increased costs as we
strengthened our business development efforts in the US as
indicated at the time of our equity fundraise in July
2023.
The total charge for share based
payments in the period was £0.5m (2023 H1: £0.4m) with the rise
reflecting a higher number of participants as we increased our
headcount. Within administrative expenses, depreciation and
amortisation increased to £2.6m (2023 H1 £1.5m) as capital
expenditure increased for the US platform build following the
California contract win.
Adjusted EBITDA for the full year is
expected to be comfortably in line with market expectations, taking
account of the fact that certain costs are skewed to the second
half.
Taxation
The overall tax charge for the
period was £1.1m (2023 H1: £1.2m credit) due predominantly to
taxable profits accumulated in the US. This is partly offset by
expected Research and Development expenditure credits in the UK.
The prior period credit related to Research and Development
expenditure credits and taxable losses.
Profit after tax
The Group profit after tax for the
period was £3.9m (2023 H1: £0.5m loss). Basic earnings per share
were 11p (2023 H1: 2p loss). Diluted earnings per share were 10p
(2023 H1: 2p loss).
Balance Sheet
The strength of the Group's balance
sheet with net assets of £25.3m (2023 H1: £10.6m), and high levels
of recurring revenue provide the Group with financial strength to
execute on its investment strategy which continues to focus on US
business development and platform investment.
Cash flow and financing
Cash inflow during the six months
was £3.9m (2023 H1: £2.6m outflow). The focus on US platform
investment gave rise to capital expenditure of £3.9m (2023 H1:
£3.5m), offset by cash inflows from operating activities of £7.7m
giving a net cash position at 30 June 2024 of £14.9m (2023 H1:
£5.9m). The Group remains debt free and maintains an undrawn $9.5m
working capital credit facility.
Forward-looking statements
Certain statements in this half year
report are forward looking. Although the Group believes that the
expectations reflected in these forward-looking statements are
reasonable, it can give no assurance that these expectations will
prove to have been correct. Because these statements involve risks
and uncertainties, actual results may differ materially from those
expressed or implied by these forward-looking
statements.
Dividends
The Group's intention in the short
to medium term is to invest in order to deliver capital growth for
shareholders. The Board has not recommended an interim dividend
payment in respect of the six months ended 30 June 2024 (2023:
£nil) but may do so in future years.
Sanjay Jawa
Chief Financial Officer
Condensed Consolidated Statement of
Comprehensive Income
For the six months ended 30 June
2024
|
Note
|
Six
months ended 30 June 2024
Unaudited
|
Six
months ended 30 June 2023
Unaudited
|
Year ended 31 December 2023
Audited
|
|
|
£'000
|
£'000
|
£'000
|
|
|
|
|
|
Revenue
|
8
|
32,494
|
11,660
|
33,337
|
Cost of sales
|
9
|
(5,727)
|
(3,872)
|
(7,480)
|
|
|
|
|
|
Gross profit
|
|
26,767
|
7,788
|
25,857
|
|
|
|
|
|
Administrative expenses
|
9
|
(22,078)
|
(9,606)
|
(28,119)
|
|
|
|
|
|
Operating Profit/(Loss)
|
|
4,689
|
(1,818)
|
(2,262)
|
|
|
|
|
|
Analysed as:
|
|
|
|
|
Adjusted EBITDA
|
|
7,841
|
9
|
2,257
|
Depreciation &
amortisation
|
12
|
(2,607)
|
(1,451)
|
(3,775)
|
Share based payment
expense
|
|
(545)
|
(376)
|
(744)
|
|
|
|
|
|
Operating Profit/(Loss)
|
|
4,689
|
(1,818)
|
(2,262)
|
|
|
|
|
|
Interest income
|
|
301
|
91
|
298
|
|
|
|
|
|
Profit/(Loss) before tax
|
|
4,990
|
(1,727)
|
(1,964)
|
|
|
|
|
|
Tax
|
10
|
(1,070)
|
1,202
|
1,795
|
|
|
|
|
|
Profit/(Loss) after tax
|
|
3,920
|
(525)
|
(169)
|
|
|
|
|
|
Other comprehensive income/(expense)
|
|
|
|
|
Items that are or may be
reclassified subsequently to profit or loss:
|
|
|
|
|
Foreign currency translation
differences
|
|
72
|
-
|
(161)
|
Total comprehensive Profit/(loss) for the
period
|
|
3,992
|
(525)
|
(330)
|
|
|
|
|
|
Profit/(Loss) per share - basic (£)
|
11
|
0.11
|
(0.02)
|
(0.00)
|
Profit/(Loss) per share - diluted (£)
|
11
|
0.10
|
(0.02)
|
(0.00)
|
|
|
|
|
|
Condensed Consolidated Balance
Sheet
As at 30 June 2024
|
Note
|
30
June 2024
Unaudited
|
30
June 2023
Unaudited
|
31
December 2023
Audited
|
|
|
£'000
|
£'000
|
£'000
|
Assets
|
|
|
|
|
Non-current assets
|
|
|
|
|
Goodwill
|
|
511
|
511
|
511
|
Development costs
|
12
|
10,179
|
5,794
|
8,750
|
Right of use asset
|
|
31
|
53
|
42
|
Property, plant and
equipment
|
|
302
|
150
|
304
|
Deferred tax asset
|
|
1,537
|
1,626
|
2,649
|
|
|
|
|
|
Total non-current assets
|
|
12,560
|
8,134
|
12,256
|
|
|
|
|
|
Current assets
|
|
|
|
|
Trade and other
receivables
|
13
|
6,234
|
2,355
|
7,174
|
Contract assets
|
|
2,157
|
180
|
251
|
Cash and cash equivalents
|
|
14,940
|
5,850
|
11,004
|
|
|
|
|
|
Total current assets
|
|
23,331
|
8,385
|
18,429
|
|
|
|
|
|
Total assets
|
|
35,891
|
16,519
|
30,685
|
|
|
|
|
|
Liabilities
|
|
|
|
|
Current liabilities
|
|
|
|
|
Trade payables
|
|
(1,001)
|
(1,047)
|
(1,555)
|
Contract liabilities
|
|
(5,738)
|
(3,096)
|
(5,156)
|
Lease liability
|
|
(34)
|
(54)
|
(44)
|
Accruals and other
creditors
|
|
(3,551)
|
(913)
|
(2,521)
|
Tax liabilities
|
|
(312)
|
(769)
|
(651)
|
|
|
|
|
|
Total current liabilities
|
|
(10,636)
|
(5,879)
|
(9,927)
|
|
|
|
|
|
Net
current assets
|
|
12,694
|
2,506
|
8,502
|
|
|
|
|
|
Net
assets
|
|
25,255
|
10,640
|
20,758
|
|
|
|
|
|
Equity
|
|
|
|
|
Share capital
|
|
1,831
|
1,653
|
1,825
|
Share premium account
|
|
23,444
|
14,229
|
23,444
|
Retained earnings
|
|
1,627
|
(3,120)
|
(2,503)
|
Share-based payment
reserve
|
|
2,431
|
1,867
|
2,142
|
Capital redemption
reserve
|
|
115
|
115
|
115
|
Merger reserve
|
|
(4,104)
|
(4,104)
|
(4,104)
|
Translation reserve
|
|
(89)
|
-
|
(161)
|
|
|
|
|
|
Total equity
|
|
25,255
|
10,640
|
20,758
|
Condensed Consolidated Statement of
Changes in Equity
For the six months ended 30 June
2024
|
Share capital
|
Share premium
|
Share Based Payment reserve
|
Retained earnings
|
Capital Redemption reserve
|
Merger reserve
|
Translation reserve
|
Total equity
|
|
|
|
|
|
|
|
|
|
Balance at 1 January 2023
|
1,653
|
14,229
|
1,221
|
(2,595)
|
115
|
(4,104)
|
-
|
10,519
|
|
|
|
|
|
|
|
|
|
Share based payments
|
-
|
-
|
646
|
-
|
-
|
-
|
-
|
646
|
Comprehensive income for the
period
|
-
|
-
|
-
|
(525)
|
-
|
-
|
-
|
(525)
|
As
at 30 June 2023
|
1,653
|
14,229
|
1,867
|
(3,120)
|
115
|
(4,104)
|
-
|
10,640
|
|
|
|
|
|
|
|
|
|
Balance at 1 July 2023
|
1,653
|
14,229
|
1,867
|
(3,120)
|
115
|
(4,104)
|
-
|
10,640
|
|
|
|
|
|
|
|
|
|
Comprehensive income for the
period
|
-
|
-
|
-
|
356
|
-
|
-
|
-
|
356
|
Other comprehensive
income
|
-
|
-
|
-
|
-
|
-
|
-
|
(161)
|
(161)
|
Total comprehensive
income
|
1,653
|
14,229
|
1,867
|
(2,764)
|
115
|
(4,104)
|
(161)
|
10,835
|
Transactions with owners:
|
|
|
|
|
|
|
|
|
Share options exercised
|
7
|
-
|
(261)
|
261
|
-
|
-
|
-
|
7
|
Share based payments
|
-
|
-
|
120
|
-
|
-
|
-
|
-
|
120
|
Shares issued
|
165
|
9,215
|
-
|
-
|
-
|
-
|
-
|
9,380
|
Deferred tax
|
-
|
-
|
416
|
-
|
-
|
-
|
-
|
416
|
As
at 31 December 2023
|
1,825
|
23,444
|
2,142
|
(2,503)
|
115
|
(4,104)
|
(161)
|
20,758
|
|
|
|
|
|
|
|
|
|
Balance at 1 January 2024
|
1,825
|
23,444
|
2,142
|
(2,503)
|
115
|
(4,104)
|
(161)
|
20,758
|
|
|
|
|
|
|
|
|
|
Comprehensive income for the
period
|
-
|
-
|
-
|
3,920
|
-
|
-
|
-
|
3,920
|
Other comprehensive
income
|
-
|
-
|
-
|
-
|
-
|
-
|
72
|
72
|
Total comprehensive
income
|
1,825
|
23,444
|
2,142
|
1,417
|
115
|
(4,104)
|
(89)
|
24,750
|
Transactions with owners:
|
|
|
|
|
|
|
|
|
Share options exercised
|
6
|
-
|
(210)
|
210
|
-
|
-
|
-
|
6
|
Share based payments
|
-
|
-
|
499
|
-
|
-
|
-
|
-
|
499
|
As
at 30 June 2024
|
1,831
|
23,444
|
2,431
|
1,627
|
115
|
(4,104)
|
(89)
|
25,255
|
|
|
|
|
|
|
|
|
|
| |
Condensed Consolidated Statement of
Cash Flows
For the six months ended 30 June
2024
|
|
Six
months ended 30 June 2024
Unaudited
|
Six
months ended 30 June 2023
Unaudited
|
Year ended 31 December 2023
Audited
|
|
|
£'000
|
£'000
|
£'000
|
Cash flows from operating activities
|
|
|
|
|
|
|
|
|
|
Profit/(Loss) for the period
|
|
3,920
|
(525)
|
(169)
|
|
|
|
|
|
Adjusted for:
|
|
|
|
|
Depreciation &
amortisation
|
|
2,607
|
1,451
|
3,775
|
Income tax
(paid)/received
|
|
(456)
|
569
|
569
|
Share based payment
expense
|
|
545
|
376
|
744
|
Tax expense/(income)
recognised
|
|
1,070
|
(1,202)
|
(1,795)
|
Interest income
|
|
(301)
|
(91)
|
(298)
|
|
|
|
|
|
Movements in working capital:
|
|
|
|
|
(Increase)/decrease in trade and
other receivables
|
|
(966)
|
651
|
(4,158)
|
Increase / (decrease) in trade and
other payables
|
|
1,240
|
(384)
|
3,199
|
Net
cashflow from operating activities
|
|
7,659
|
845
|
1,867
|
|
|
|
|
|
Cash flows from investing activities
|
|
|
|
|
Purchase of property, plant and
equipment
|
|
(77)
|
(70)
|
(291)
|
Additions to intangible
assets
|
|
(3,947)
|
(3,508)
|
(8,713)
|
Interest income
|
|
301
|
91
|
298
|
Net
cash used in investing activities
|
|
(3,723)
|
(3,487)
|
(8,706)
|
|
|
|
|
|
Cash flows from financing activities
|
|
|
|
|
Proceeds from issue of share
capital
|
|
-
|
-
|
9,923
|
Costs incurred from the issue of
share capital
|
|
-
|
-
|
(536)
|
Net
cash from financing activities
|
|
-
|
-
|
9,387
|
|
|
|
|
|
Net
increase / (decrease) in cash and cash
equivalents
|
|
3,936
|
(2,642)
|
2,548
|
Exchange adjustments
|
|
-
|
-
|
(36)
|
Cash and cash equivalents at the
beginning of the period
|
|
11,004
|
8,492
|
8,492
|
Cash and cash equivalents at the end
of the period
|
|
14,940
|
5,850
|
11,004
|
Notes to the half year financial
statements
1.
General information
The unaudited interim consolidated
financial statements for the six months ended 30 June 2024 and the
six months ended 30 June 2023 do not constitute statutory accounts
within the meaning of Section 434 of the Companies Act 2006.
Statutory accounts for the year ended 31 December 2023 were
approved by the Board of Directors on 25 March 2024 and delivered
to the Registrar of Companies. The auditor's report on those
accounts was unqualified, did not contain an emphasis of matter
paragraph and did not contain any statement under Section 498 (2)
or (3) of the Companies Act 2006.
These condensed half year financial
statements were approved for issue by the Board of Directors on 16
September 2024.
2.
Basis of preparation
This unaudited condensed
consolidated financial information which incorporate the financial
information of the Group, have been prepared in accordance with
Accounting Standard IAS 34 'Interim Financial Reporting' as
contained in UK - adopted International Accounting Standards and
IFRIC interpretations and with those parts of the Companies Act
2006 applicable to companies reporting under IFRS.
The interim condensed consolidated
financial statements do not include all the information and
disclosures required in the annual financial statements and should
be read in conjunction with the Group's annual consolidated
financial statements prepared in accordance with international
accounting standards in conformity with the requirements of the
Companies Act 2006 for the year ended 31 December 2023.
Trading for the half year ended 30
June 2024 is aligned with the Board's expectations, and management
expectations for the full year remain unchanged. Further details
are given in the CEO's overview, the operational review and the
financial review.
During the period the Group has
generated a profit of £3.9m (2023 H1: loss of £0.5m) and is in a
net asset position of £25.3m as at 30 June 2024 (2023 H1: net
assets of £10.6m). Management have prepared forecasts up until 12
months from the date of approval of these financial statements
which have been approved by the Board, and after enquiry and review
of these forecasts and other available financial information, the
Directors have formed the conclusion that the Group has adequate
resources to continue to operate for the foreseeable future and
that it is therefore appropriate to continue to adopt the going
concern basis of accounting in the preparation of these interim
condensed consolidated half year financial statements.
The financial information is
presented in sterling, which is the functional currency of Kooth
plc. All financial information presented has been rounded to the
nearest thousand.
3.
Accounting policies
The accounting policies applied in
these interim financial statements are the same as those applied in
the Group's annual report and accounts for the year ended 31
December 2023.
Current taxes on income in the half
year period are accrued using the tax rates that would be
applicable to expected total annual profits. Deferred taxes on
income are calculated based on the standard rates that are enacted
as at the balance sheet date.
4.
Critical accounting judgements and key sources of estimation
uncertainty
Any critical accounting judgements
and key sources of estimation uncertainty that carry a significant
risk of material change to the carrying value of assets and
liabilities within the next year are the same as those applied in
the 2023 Group Annual Report.
5.
Principal risks and uncertainties
The 2023 Group annual report and
accounts describes the principal risks and uncertainties that could
impact the Group's performance. These risks primarily relate to
system outages, safeguarding incidents, changes in laws and
regulations and cyber security and data protection, our people and
the economic environment. These remain unchanged since the annual
report was published and are not expected to change for the
remaining six months of the financial year.
The Group actively manages these
risks through risk management procedures and actions are taken to
mitigate risk wherever possible.
6.
Financial risk management
The Group is exposed to financial
risks including market risk, foreign currency risk, credit risk and
liquidity risk.
These interim condensed consolidated
financial statements do not include all financial risk management
information and disclosures required in the annual financial
statements and therefore should be read in conjunction with the
2023 Group annual report and accounts.
7.
Segmental reporting
Operating segments are reported in a
manner consistent with the internal reporting provided to the chief
operating decision-maker (CODM). The chief operating
decision-maker, who is responsible for allocating resources and
assessing performance of the operating segments, has been
identified as the executive directors that make strategic
decisions. Accordingly, the CODM determines the Group currently
operates under one reporting segment.
8.
Revenue analysis
The total turnover of Kooth plc has
been derived from its principal activity undertaken in the UK and
the US. A geographical analysis of revenue by customer location is
provided below:
|
Six
months ended 30 June 2024
Unaudited
|
|
Six
months ended 30 June 2023
Unaudited
|
|
Year ended 31 December 2023
Audited
|
|
£'000
|
|
£'000
|
|
£'000
|
Provision of online counselling
contracts - UK
|
9,243
|
|
9,817
|
|
19,143
|
Provision of online counselling
contracts - US
|
-
|
|
1,466
|
|
1,466
|
Platform build and behavioural
support services contracts - US
|
23,251
|
|
377
|
|
12,728
|
|
32,494
|
|
11,660
|
|
33,337
|
9.
Operating profit/(loss)
|
Six
months ended 30 June 2024
Unaudited
|
|
Six
months ended 30 June 2023
Unaudited
|
|
Year ended 31 December 2023
Audited
|
|
£'000
|
|
£'000
|
|
£'000
|
Labour costs
|
5,600
|
|
3,821
|
|
7,354
|
Share based payment
expense
|
122
|
|
35
|
|
100
|
Travel and subsistence
|
5
|
|
16
|
|
26
|
Total cost of sales
|
5,727
|
|
3,872
|
|
7,480
|
Labour costs
|
14,115
|
|
5,583
|
|
15,855
|
Rent and rates
|
308
|
|
260
|
|
492
|
IT hosting and software
|
1,200
|
|
692
|
|
1,450
|
Professional fees
|
1,645
|
|
948
|
|
3,948
|
Marketing
|
1,626
|
|
286
|
|
1,650
|
Depreciation and
amortisation
|
2,607
|
|
1,451
|
|
3,775
|
Share based payment
expense
|
424
|
|
341
|
|
644
|
Other costs
|
154
|
|
45
|
|
305
|
Total administrative expenses
|
22,078
|
|
9,606
|
|
28,119
|
Total cost of sales and administrative
expenses
|
27,805
|
|
13,478
|
|
35,599
|
Cost of sales represent the costs of
our service user facing employees including external
contractors.
10.
Taxation
The income tax charge recognised
£1.1m (2023 H1: £1.2m credit) reflects management's estimate of the
tax charge for the current period. This calculation takes into
consideration the estimated taxable profit incurred from
operational activities during the period, as well as relief earned
under the UK R&D scheme. The assessment utilises the 25%
average UK corporation tax rate (2023: 23.5%), the 21% average US
federal tax rate (2023: 21%) and 8.8% average California state tax
rate (2023: 8.8%) for the current financial year.
11.
Earnings per share (EPS)
The calculation of basic and diluted
EPS is based on the following earnings and number of
shares:
|
Six
months ended 30 June 2024
Unaudited
|
Six
months ended 30 June 2023
Unaudited
|
Year ended 31 December 2023
Audited
|
|
|
|
|
|
|
|
|
|
£'000
|
£'000
|
£'000
|
Earnings used in calculation of earnings per
share
|
|
|
|
Profit/(Loss) for the purposes of
basic and diluted loss per share being net profit/(loss)
attributable to owners of the Company
|
3,920
|
(525)
|
(169)
|
|
|
|
|
Number of shares
|
|
|
|
Weighted average number of ordinary
shares for the purposes of basic earnings per share
|
36,537,329
|
33,055,776
|
34,768,325
|
|
|
|
|
Weighted average number of ordinary
shares for the purposes of diluted earnings per share
|
38,505,149
|
34,999,176
|
38,819,890
|
|
|
|
|
Profit/(Loss) per share - basic (£)
|
0.11
|
(0.02)
|
(0.00)
|
|
|
|
|
Profit/(Loss) per share - diluted (£)
|
0.10
|
(0.02)
|
(0.00)
|
12.
Development costs
|
£'000
|
Cost
|
|
At
1 January 2023
|
10,315
|
Additions
|
3,508
|
At
30 June 2023
|
13,823
|
Additions
|
5,205
|
At
31 December 2023
|
19,028
|
Additions
|
3,947
|
At
30 June 2024
|
22,975
|
|
|
Amortisation
|
|
At
1 January 2023
|
(6,634)
|
Amortisation
|
(1,395)
|
At
30 June 2023
|
(8,029)
|
Amortisation
|
(2,249)
|
At
31 December 2023
|
(10,278)
|
Amortisation
|
(2,518)
|
At
30 June 2024
|
(12,796)
|
|
|
Carrying amount
|
|
At 1 January 2023
|
3,681
|
At
30 June 2023
|
5,794
|
At 31 December 2023
|
8,750
|
At
30 June 2024
|
10,179
|
13.
Trade and other receivables
|
Six
months ended 30 June 2024
Unaudited
|
|
Six
months ended 30 June 2023
Unaudited
|
|
Year ended 31 December 2023
Audited
|
|
£'000
|
|
£'000
|
|
£'000
|
Trade receivables
|
5,128
|
|
1,767
|
|
5,801
|
Prepayments and other
receivables
|
1,106
|
|
588
|
|
1,373
|
|
6,234
|
|
2,355
|
|
7,174
|
All amounts shown above are short
term. The net carrying value of trade receivables is considered a
reasonable approximation of fair value.
14.
Post balance sheet events
No significant events have taken
place after the period end date.